DOPAMINE-D2 RECEPTOR DENSITY REMAINS CONSTANT IN TREATED PARKINSONS-DISEASE

被引:97
作者
GUTTMAN, M
SEEMAN, P
REYNOLDS, GP
RIEDERER, P
JELLINGER, K
TOURTELLOTTE, WW
机构
[1] UNIV TORONTO, FAC MED, DEPT MED, TORONTO M5S 1A8, ONTARIO, CANADA
[2] ADDENBROOKES HOSP, MRC, DEPT NEUROL SURG & NEUROL, NEUROCHEM PHARMACOL UNIT, CAMBRIDGE CB2 2QQ, ENGLAND
[3] LAINZ HOSP, LUDWIG BOLTZMANN INST CLIN NEUROBIOL, A-1130 VIENNA, AUSTRIA
[4] VET ADM WADSWORTH MED CTR, NATL NEUROL RES BANK, LOS ANGELES, CA 90073 USA
关键词
D O I
10.1002/ana.410190510
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:487 / 492
页数:6
相关论文
共 41 条
[1]  
BIRKMAYER W, 1983, PARKINSONS DISEASE, P94
[2]  
BOKOBZA G, 1983, EUR J PHARMACOL, V99, P167
[3]   DOPAMINE RECEPTOR AGONISTS - INTRINSIC ACTIVITY VS STATE OF RECEPTOR [J].
CARLSSON, A .
JOURNAL OF NEURAL TRANSMISSION, 1983, 57 (04) :309-315
[4]   L-DOPA ON-OFF EFFECT IN PARKINSON DISEASE - TREATMENT BY TRANSIENT DRUG WITHDRAWAL AND DOPAMINE RECEPTOR RESENSITIZATION [J].
DIRENFELD, L ;
SPERO, L ;
MAROTTA, J ;
SEEMAN, P .
ANNALS OF NEUROLOGY, 1978, 4 (06) :573-575
[5]   L-DOPA REVERSAL OF HYPER-DOPAMINERGIC BEHAVIOR [J].
EZRINWATERS, C ;
SEEMAN, P .
LIFE SCIENCES, 1978, 22 (12) :1027-1032
[6]   SHOULD LEVODOPA THERAPY FOR PARKINSONISM BE STARTED EARLY OR LATE - EVIDENCE AGAINST EARLY TREATMENT [J].
FAHN, S ;
BRESSMAN, SB .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (01) :200-205
[7]  
FRIEDHOFF AJ, 1977, RES COMMUN CHEM PATH, V16, P411
[8]   THE DOPAMINE NEUROLEPTIC RECEPTOR [J].
GRIGORIADIS, D ;
SEEMAN, P .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (01) :108-113
[9]   MULTIPLE RECEPTORS FOR DOPAMINE [J].
KEBABIAN, JW ;
CALNE, DB .
NATURE, 1979, 277 (5692) :93-96
[10]  
LANG AE, 1984, CAN MED ASSOC J, V131, P1031